Mark Coleman - 08 Jun 2026 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Reporting relationship: Director
Issuer ticker: AXSM
Reported as of: 08 Jun 2026
Net transaction value: -$160,107
SEC form: 4
Accepted by SEC: 10 Jun 2026, 21:49:14 UTC
Prior SEC filing: 09 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Nick Pizzie, Attorney-in-Fact

Key filing fact

Mark Coleman filed Form 4 for Axsome Therapeutics, Inc. (AXSM) on 10 Jun 2026.

Key facts

This page summarizes Mark Coleman's Form 4 filing for Axsome Therapeutics, Inc. (AXSM).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 10 Jun 2026, 21:49.

Change

Previous filing in this sequence was filed on 09 Jun 2026.
Current net transaction value: -$160,107.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001658379 Primary reporting owner

Coleman Mark

Relationship: Director
Address: C/O AXSOME THERAPEUTICS, INC., ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
Signature: /s/ Nick Pizzie, Attorney-in-Fact
Signature date: 10 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AXSM transaction

Common Stock

Options Exercise

Transaction value
Shares: +1,429
Change %: +4.8%
Price
Shares after: 31,032
Date: 08 Jun 2026
Ownership: Direct
Footnotes: F1, F2

AXSM transaction

Common Stock

Sale

Transaction value: $160,107
Shares: -643
Change %: -2.1%
Price: $249.00
Shares after: 30,389
Date: 10 Jun 2026
Ownership: Direct
Footnotes: F3, F4, F5

AXSM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 403,856
Date: 08 Jun 2026
Ownership: See Footnote
Footnotes: F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AXSM transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -1,429
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 08 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,429
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

Footnote F2

On June 6, 2025, the Reporting Person was granted 1,429 RSUs, all of which vested upon the one-year anniversary of the date of grant.

Footnote F3

Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed.

Footnote F4

These shares were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on June 6, 2025.

Footnote F5

Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $245.17 and $253.04.

Footnote F6

Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.